LAVA Therapeutics N.V. Ordinary Shares
N/A
USD
N/A
N/A
...
Chart
Financials
Description
LVTX Company Description
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.
LVTX Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view LVTX Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of LVTX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by LVTX's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of LVTX in WallStreetBets Daily Discussion
LVTX News
Recent insights relating to LVTX
CNBC Recommendations
Recent picks made for LVTX stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in LVTX
Corporate Flights
Flights by private jets registered to LVTX
Our Analysis